This pregnancy was complicated by preeclampsia diagnosed in the month prior to delivery treated most recently with magnesium sulfate and labetalol and betamethasone.
Induction was undertaken for worsening PIH and progressed to cesarean section under epidural anesthesia due to fetal intolerance to labor.
HOSPITAL COURSE BY SYSTEMS: Respiratory status:  The infant required nasal cannula oxygen for the first four days of life and then required continuous positive airway pressure on day of life #5 for increasing work of breathing.
She then weaned to nasal cannula again on day of life seven and then to room air on day of life #8, where she remained at the time of transfer.
She was started on caffeine citrate on day of life #4 for her apnea, and continues on that at the time of transfer.
Enteral feeds were begun on day of life #1, and advanced without difficulty to full volume feedings by day of life #5.
At the time of transfer, she is eating total fluids of 150 cc/kg/day of breast milk 26 cal/ounce made with 4 calories/ounce of milk fortifier, and 2 calories/ounce of medium chain triglyceride oil.
Gastrointestinal status:  She was treated with phototherapy for hyperbilirubinemia of prematurity since day of life #1 until day of life #4.
She has received no blood products by transfusion during this NICU stay.
Infectious disease status:  The infant was started on ampicillin and gentamicin at time of admission to the NICU for sepsis risk factors.
The antibiotics were discontinued after 48 hours, and the infant was clinically well, and the blood cultures remained negative.
CARE AND RECOMMENDATIONS:  At the time of transfer, in terms of feedings, the infant is on feeds of mother's milk 26 calories/ounce, total fluids of 150 cc/kg/day with additives of 4 calories/ounce of human milk fortifier, 2 calories/ounce of medium chain triglyceride oil, and added ProMod 1.5 teaspoon of ProMod to 100 cc of breast milk.
Caffeine citrate 7.5 mg po q day.
Iron sulfate (25 mg of elemental iron/cc), 0.1 cc of PG q day.
Vitamin E 5 IU pg q day.
The infant has not yet received any immunizations.
Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  1) Born at less than 32 weeks, 2) born between 32 and 35 weeks with plans for daycare during RSV season, with a smoker in the household, or with preschool siblings, or 3) with chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age, the family and other caregivers should be considered for immunization against influenza to protect the infant.
